Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DQRF vs Topical Corticosteroids in Vulvar Lichen Sclerosus
NCT07363733Recruiting
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in vulvar lichen sclerosus (LS) (2 arms). Primary endpoint: Change in clinical severity of vulvar lichen sclerosus at 12 months. Started Jan 2026; status: recruiting.
02
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT07363733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07363733.